Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

30.0%

3 terminated/withdrawn out of 10 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05308979Phase 4Completed

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

Role: collaborator

NCT02008656Phase 2Active Not Recruiting

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Role: collaborator

NCT03000751Not ApplicableCompleted

CT DOSE Collaboratory

Role: collaborator

NCT01295723Not ApplicableUnknown

Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT)

Role: lead

NCT01688388Not ApplicableCompleted

Single Fraction Intraoperative Radiotherapy

Role: lead

NCT04517682Completed

COVID-19 and SARS-CoV-2 Detection in Saliva

Role: collaborator

NCT00877136Completed

A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

Role: lead

NCT00892255Withdrawn

Microwave Ablation of Resectable Liver Tumors

Role: lead

NCT01376661Terminated

Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study

Role: lead

NCT04828044Withdrawn

Microwave Ablation of Breast Tumors

Role: lead

All 10 trials loaded